News

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

by

VIENNA, May 11, 2023 /PRNewswire/ — Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company’s botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these countries in the coming … Read more

CEAT Ambernath plant receives five-star grading in British Safety Council Audit

by

CEAT Specialty (division of CEAT Tyres) is proud to announce that it’s Ambernath facility has received a Five Star rating in the Occupational Health and Safety Audit conducted by the British Safety Council MUMBAI, India, May 11, 2023 /PRNewswire/ — The company’s Ambernath plant underwent a comprehensive, quantified, and robust evaluation of its occupational health and safety policies, processes … Read more

CEAT Ambernath recibe cinco estrellas en la auditoría del Consejo Británico de Seguridad

by

– La planta de CEAT Ambernath recibe una calificación de cinco estrellas en la auditoría del Consejo Británico de Seguridad CEAT Specialty (división de CEAT Tyres) se enorgullece en anunciar que sus instalaciones de Ambernath han recibido una calificación de Cinco Estrellas en la Auditoría de Seguridad y Salud Ocupacional realizada por el Consejo Británico … Read more

CEAT Ambernath-Werk erhält Fünf-Sterne-Bewertung in British Safety Council Audit

by

CEAT Specialty (ein Geschäftsbereich von CEAT Tyres) ist stolz darauf, bekannt geben zu können, dass das Werk in Ambernath im Rahmen des vom British Safety Council durchgeführten Audits für Gesundheit und Sicherheit am Arbeitsplatz eine Fünf-Sterne-Bewertung erhalten hat. MUMBAI, Indien, 11. Mai 2023 /PRNewswire/ — Das Werk Ambernath des Unternehmens unterzog sich einer umfassenden, quantifizierten und … Read more

Les résultats positifs de premier ordre de l’essai de phase 2 montrent que le candidat-vaccin combiné COVID-Influenza de Novavax, le candidat-vaccin autonome contre la grippe et les candidats-vaccins à forte dose contre la COVID-19 présentent de solides réponses immunitaires USA – Français India – English USA – Deutsch USA – English Brazil – Português Latin America – español USA – español

by

Cet essai de phase 2 évalue trois candidats-vaccins : Candidat-vaccin combiné COVID-Influenza, candidat-vaccin autonome contre la grippe et candidat-vaccin à forte dose contre la COVID-19 Les réponses immunitaires initiales de premier ordre des trois candidats-vaccins étaient robustes par rapport aux comparateurs autorisés Pour le candidat-vaccin antigrippal autonome, les réponses de l’IH étaient de 31 à 56 % … Read more

Veeva s’associe à Sanofi pour transformer son système de qualité

by

Une entreprise pharmaceutique de premier plan pour rationaliser les processus de qualité dans l’ensemble de l’entreprise BARCELONE, Espagne, 11 mai 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a annoncé aujourd’hui que Sanofi mettait en œuvre Veeva Vault QMS et Veeva Vault QualityDocs pour moderniser la gestion de la qualité dans l’ensemble de l’entreprise, y compris dans le domaine de la santé grand public … Read more

Pharming Group reports financial results for the first quarter of 2023

by

FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues decreased by 9% to US$42.5 million, compared to the first quarter of 2022, primarily due to temporary reimbursement disruptions for some patients on government insurance programs. This issue, affecting all … Read more

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

by

UCB’s expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum’s discovery of treatments for solid tumors Ariceum’s expertise in radiopharmaceuticals and labelling technology will aid UCB’s discovery of treatments for immune-related diseases Potential to expand Ariceum’s pipeline with three new programs at discovery stage BERLIN and BRUSSELS, May 11, 2023 … Read more

Niklas Prager appointed new CEO of SmartCella

by

STOCKHOLM, May 11, 2023 /PRNewswire/ — SmartCella Holding AB today announces that Niklas Prager has been appointed as the new CEO. SmartCella is an innovative biotech and medtech company that combines targeted delivery of medical substances to organs and tumors through a unique device, and the development of future stemcell and RNA-based treatments and methods … Read more

BioInnovation Institute appointed by the Danish government to run international deep tech start-up accelerator to unlock the potential in quantum science

by

COPENHAGEN, Denmark, May 11, 2023 /PRNewswire/ — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, announces the launch of a new deep tech accelerator start-up program, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace. Deep tech and quantum … Read more